Turk Psikiyatri Derg. 2021 Spring;32(1):65-69. doi: 10.5080/u23768.
Self-injurious behaviors (SIBs) in autism spectrum disorder (ASD) are destructive symptoms that can lead to dangerous injuries and life-threatening risks. Agitation and SIBs may not respond to psychopharmacological and behavioral interventions. There are reports in the literature on improvement after electroconvulsive therapy (ECT) in cases not responding pharmacotherapy. However, data on the efficacy of the therapy on the benefiting patients, the course of the treatment and on the use of maintenance ECT (m-ECT) are very limited. This report presents the clinical features and the course of m-ECT on two cases under follow up for pharmacotherapy resistant ASD with significant agitation, mood disorder and SIBs that could cause severe head traumas. The initial stage of therapy consisted of 7 sessions of ECT patients showed improvement after the 5th session. m-ECT were started since the agitation repeated one week after discharge despite ongoing pharmacotherapy. In the first case, m-ECT was continued once every two weeks for a total of 46 sessions; and in the second case a total of 18 weekly sessions were conducted. No significant side effects or complications were observed and the general state of well-being was preserved. Our paper is among the few that reported succesful treatment of agitation with m-ECT. m-ECT should be considered in treatment resistant cases.
自闭症谱系障碍(ASD)中的自伤行为(SIB)是破坏性症状,可导致危险的伤害和危及生命的风险。躁动和 SIB 可能对精神药理学和行为干预没有反应。文献中有报道称,在药物治疗无效的情况下,电惊厥疗法(ECT)后会有所改善。然而,关于该疗法对受益患者的疗效、治疗过程以及维持性 ECT(m-ECT)的使用的数据非常有限。本报告介绍了两例接受药物治疗抵抗的 ASD 患者的临床特征和 m-ECT 治疗过程,这些患者有明显的躁动、情绪障碍和 SIB,可能导致严重的头部创伤。治疗的初始阶段包括 7 次 ECT,患者在第 5 次治疗后有所改善。尽管正在进行药物治疗,但在出院后一周,躁动仍会反复出现,因此开始进行 m-ECT。在第一个病例中,m-ECT 每两周进行一次,共进行了 46 次;第二个病例总共进行了 18 次每周治疗。未观察到明显的副作用或并发症,整体健康状况得以保持。我们的论文是少数成功报告使用 m-ECT 治疗躁动的论文之一。对于药物治疗抵抗的病例,应考虑进行 m-ECT。